Cancer‑associated fibroblast‑derived LRRC15 promotes the migration and invasion of triple‑negative breast cancer cells via Wnt/β‑catenin signalling pathway regulation

Yang,Yang; Wu,Haiying; Fan,Shaoxia; Bi,Yanqing; Hao,Min; Shang,Jian

doi:10.3892/mmr.2021.12518

Cancer‑associated fibroblast‑derived LRRC15 promotes the migration and invasion of triple‑negative breast cancer cells via Wnt/β‑catenin signalling pathway regulation

Authors:
- Yang Yang
- Haiying Wu
- Shaoxia Fan
- Yanqing Bi
- Min Hao
- Jian Shang
View Affiliations

Affiliations: Department of Breast and Thyroid Surgery, Dongying People's Hospital, Dongying, Shandong 257091, P.R. China
Published online on: November 2, 2021 https://doi.org/10.3892/mmr.2021.12518
Article Number: 2
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Triple‑negative breast cancer (TNBC) is a highly aggressive tumour subtype associated with poor prognosis. The function of leucine‑rich repeat‑containing protein 15 (LRRC15), a member of the leucine‑rich repeat superfamily, in TNBC has not yet been elucidated. The aim of this study was to identify the combined role of LRRC15 and Wnt/β‑catenin signalling pathway in the development of TNBC. The expression of LRRC15 in TNBC tissues was analysed using data from The Cancer Genome Atlas. Cell migration and invasion assays were conducted to study the function of LRRC15 in TNBC. The expression of Wnt/β‑catenin signalling proteins was analysed via western blotting. The effect of LRRC15 on β‑catenin nuclear localisation was measured by performing western blotting and luciferase assays. It was found that high LRRC15 expression was associated with poor prognosis in patients with TNBC. High expression of LRRC15 in cancer‑associated fibroblasts (CAFs) promoted cell migration and invasion in TNBC cells. In addition, TNBC cells with LRRC15 overexpression in CAFs showed an aberrant increase in β‑catenin activity concomitant with nuclear localisation of β‑catenin, which inhibited its degradation. These results showed that LRRC15 promoted tumour migration and invasion in TNBC cells by regulating the Wnt/β‑catenin signalling pathway.

View Figures

View References

1	Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, et al: American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 28:2784–2795. 2010. View Article : Google Scholar : PubMed/NCBI
2	Bergin ART and Loi S: Triple-negative breast cancer: Recent treatment advances. F1000Res. 8:F10002019. View Article : Google Scholar : PubMed/NCBI
3	Sharma P: Biology and management of patients with triple-negative breast cancer. Oncologist. 21:1050–1062. 2016. View Article : Google Scholar : PubMed/NCBI
4	Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P and Narod SA: Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
5	Yao H, He G, Yan S, Chen C, Song L, Rosol TJ and Deng X: Triple-negative breast cancer: Is there a treatment on the horizon? Oncotarget. 8:1913–1924. 2017. View Article : Google Scholar : PubMed/NCBI
6	Pickup MW, Mouw JK and Weaver VM: The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 15:1243–1253. 2014. View Article : Google Scholar : PubMed/NCBI
7	Satoh K, Hata M and Yokota H: A novel member of the leucine-rich repeat superfamily induced in rat astrocytes by beta-amyloid. Biochem Biophys Res Commun. 290:756–762. 2002. View Article : Google Scholar : PubMed/NCBI
8	Purcell JW, Tanlimco SG, Hickson J, Fox M, Sho M, Durkin L, Uziel T, Powers R, Foster K, McGonigal T, et al: LRRC15 Is a novel mesenchymal protein and stromal target for antibody-drug conjugates. Cancer Res. 78:4059–4072. 2018. View Article : Google Scholar : PubMed/NCBI
9	Ben-Ami E, Perret R, Huang Y, Courgeon F, Gokhale PC, Laroche-Clary A, Eschle BK, Velasco V, Le Loarer F, Algeo MP, et al: LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications. Cancers (Basel). 12:122020. View Article : Google Scholar : PubMed/NCBI
10	Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D, et al: Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res. 66:5278–5286. 2006. View Article : Google Scholar : PubMed/NCBI
11	Rahman FU, Ali A, Khan IU, Duong HQ, Guo R, Wang H, Li ZT and Zhang DW: Novel phenylenediamine bridged mixed ligands dimetallic square planner Pt(II) complex inhibits MMPs expression via p53 and caspase-dependent signaling and suppress cancer metastasis and invasion. Eur J Med Chem. 125:1064–1075. 2017. View Article : Google Scholar : PubMed/NCBI
12	Eiseler T, Döppler H, Yan IK, Goodison S and Storz P: Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion. Breast Cancer Res. 11:R132009. View Article : Google Scholar : PubMed/NCBI
13	Liu J, Liu M, Wang S, He Y, Huo Y, Yang Z and Cao X: Alantolactone induces apoptosis and suppresses migration in MCF 7 human breast cancer cells via the p38 MAPK, NF κB and Nrf2 signaling pathways. Int J Mol Med. 42:1847–1856. 2018.PubMed/NCBI
14	Khan M, Muzumdar D and Shiras A: Attenuation of tumor suppressive function of FBXO16 ubiquitin ligase activates Wnt signaling in glioblastoma. Neoplasia. 21:106–116. 2019. View Article : Google Scholar : PubMed/NCBI
15	Zhang F, Cui JY, Gao HF, Yu H, Gao FF, Chen JL and Chen L: Cancer-associated fibroblasts induce epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer via CXCL12/CXCR4 axis. Future Oncol. 16:2619–2633. 2020. View Article : Google Scholar : PubMed/NCBI
16	Mariani A, Wang C, Oberg AL, Riska SM, Torres M, Kumka J, Multinu F, Sagar G, Roy D, Jung DB, et al: Genes associated with bowel metastases in ovarian cancer. Gynecol Oncol. 154:495–504. 2019. View Article : Google Scholar : PubMed/NCBI
17	Klein A, Olendrowitz C, Schmutzler R, Hampl J, Schlag PM, Maass N, Arnold N, Wessel R, Ramser J, Meindl A, et al: Identification of brain- and bone-specific breast cancer metastasis genes. Cancer Lett. 276:212–220. 2009. View Article : Google Scholar : PubMed/NCBI
18	Zhou J, Wang XH, Zhao YX, Chen C, Xu XY, Sun Q, Wu HY, Chen M, Sang JF, Su L, et al: Cancer-associated fibroblasts correlate with tumor-associated macrophages infiltration and lymphatic metastasis in triple negative breast cancer patients. J Cancer. 9:4635–4641. 2018. View Article : Google Scholar : PubMed/NCBI
19	Houthuijzen JM and Jonkers J: Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment. Cancer Metastasis Rev. 37:577–597. 2018. View Article : Google Scholar : PubMed/NCBI
20	Paolillo M and Schinelli S: Extracellular Matrix Alterations in Metastatic Processes. Int J Mol Sci. 20:202019. View Article : Google Scholar
21	Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res. 92:827–839. 2003. View Article : Google Scholar : PubMed/NCBI
22	Pittayapruek P, Meephansan J, Prapapan O, Komine M and Ohtsuki M: Role of matrix metalloproteinases in photoaging and photocarcinogenesis. Int J Mol Sci. 17:172016. View Article : Google Scholar
23	Qin H, Liu X, Li F, Miao L, Li T, Xu B, An X, Muth A, Thompson PR, Coonrod SA, et al: PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling. Cancer Lett. 409:30–41. 2017. View Article : Google Scholar : PubMed/NCBI
24	Satriyo PB, Bamodu OA, Chen JH, Aryandono T, Haryana SM, Yeh CT and Chao TY: Cadherin 11 inhibition downregulates β-catenin, deactivates the canonical WNT signalling pathway and suppresses the cancer stem cell-like phenotype of triple negative breast cancer. J Clin Med. 8:82019. View Article : Google Scholar
25	Zhu X, Wang K, Zhang K, Xu F, Yin Y, Zhu L and Zhou F: Galectin-1 knockdown in carcinoma-associated fibroblasts inhibits migration and invasion of human MDA-MB-231 breast cancer cells by modulating MMP-9 expression. Acta Biochim Biophys Sin (Shanghai). 48:462–467. 2016. View Article : Google Scholar : PubMed/NCBI
26	Kwon YJ, Leibovitch BA, Bansal N, Pereira L, Chung CY, Ariztia EV, Zelent A, Farias EF and Waxman S: Targeted interference of SIN3A-TGIF1 function by SID decoy treatment inhibits Wnt signaling and invasion in triple negative breast cancer cells. Oncotarget. 8:88421–88436. 2016. View Article : Google Scholar : PubMed/NCBI
27	Lv ZD, Yang ZC, Liu XP, Jin LY, Dong Q, Qu HL, Li FN, Kong B, Sun J, Zhao JJ, et al: Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer. J Cell Mol Med. 20:1640–1650. 2016. View Article : Google Scholar : PubMed/NCBI
28	Jamieson C, Sharma M and Henderson BR: Targeting the β-catenin nuclear transport pathway in cancer. Semin Cancer Biol. 27:20–29. 2014. View Article : Google Scholar : PubMed/NCBI
29	Samimi H, Haghpanah V, Irani S, Arefian E, Sohi AN, Fallah P and Soleimani M: Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor ‘BI-847325’ on anaplastic thyroid carcinoma. Daru. 27:1–7. 2019. View Article : Google Scholar : PubMed/NCBI
30	Lu FI, Sun YH, Wei CY, Thisse C and Thisse B: Tissue-specific derepression of TCF/LEF controls the activity of the Wnt/β-catenin pathway. Nat Commun. 5:53682014. View Article : Google Scholar : PubMed/NCBI
31	Barua D and Hlavacek WS: Modeling the effect of APC truncation on destruction complex function in colorectal cancer cells. PLOS Comput Biol. 9:e10032172013. View Article : Google Scholar : PubMed/NCBI
32	Karami S, Lin FM, Kumar S, Bahnassy S, Thangavel H, Quttina M, Li Y, Ren J and Bawa-Khalfe T: Novel SUMO-protease SENP7S regulates β-catenin signaling and mammary epithelial cell transformation. Sci Rep. 7:464772017. View Article : Google Scholar : PubMed/NCBI
33	Arnold HK, Zhang X, Daniel CJ, Tibbitts D, Escamilla-Powers J, Farrell A, Tokarz S, Morgan C and Sears RC: The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc. EMBO J. 28:500–512. 2009. View Article : Google Scholar : PubMed/NCBI
34	Morrow KA, Das S, Meng E, Menezes ME, Bailey SK, Metge BJ, Buchsbaum DJ, Samant RS and Shevde LA: Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancer. Oncotarget. 7:17991–18005. 2016. View Article : Google Scholar : PubMed/NCBI